These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10893967)

  • 1. [New generation protease inhibitor. Tolerance and potency, a tight association].
    MMW Fortschr Med; 2000; 142(3 Suppl):40-1. PubMed ID: 10893967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Overcoming weaknesses in therapy. Protease inhibitors with high IQ].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():96-7. PubMed ID: 11373795
    [No Abstract]   [Full Text] [Related]  

  • 3. [No resistance even after 1 year. New drug combination against HIV].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():108. PubMed ID: 11373766
    [No Abstract]   [Full Text] [Related]  

  • 4. [HIV therapy in childhood. Also once daily lopinavir/r is effective].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():55. PubMed ID: 16385877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():14-6. PubMed ID: 15373035
    [No Abstract]   [Full Text] [Related]  

  • 6. [New data on atazanavir/r]].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887
    [No Abstract]   [Full Text] [Related]  

  • 7. [First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?].
    Theobald T; Jäger H
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():28-9. PubMed ID: 16385867
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-HIV agents. Once-daily lopinavir/ritonavir (Kaletra).
    TreatmentUpdate; 2004 Mar; 16(2):3-4. PubMed ID: 17219667
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 10. Kaletra goes it alone.
    Huff B
    GMHC Treat Issues; 2003 Sep; 17(9):11. PubMed ID: 14672062
    [No Abstract]   [Full Text] [Related]  

  • 11. Newest protease inhibitor Kaletra has a unique profile.
    Murphy MJ
    HIV Clin; 2001; 13(1):6-7. PubMed ID: 11810817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lopinavir/r in new packaging].
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1681. PubMed ID: 12931730
    [No Abstract]   [Full Text] [Related]  

  • 13. [New treatment options for HIV-infected patients].
    Wehr A
    Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. UCB Pharma and FDA issue advisory letter.
    AIDS Alert; 2004 Feb; 19(2):22-4. PubMed ID: 15011629
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyponatraemia associated with lopinavir--ritonavir?
    Roberts MT; Aliyu SH
    Int J Infect Dis; 2007 Jan; 11(1):83-4. PubMed ID: 16574455
    [No Abstract]   [Full Text] [Related]  

  • 16. [An option even for patients with multiple pretreatment].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():97. PubMed ID: 11373796
    [No Abstract]   [Full Text] [Related]  

  • 17. Lopinavir/ritonavir. (Kaletra).
    Res Initiat Treat Action; 2000 Dec; 6(4):16-8. PubMed ID: 11708169
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HIV agents. Monotherapy studies--points to consider.
    TreatmentUpdate; 2008 Jan; 20(1):3-4. PubMed ID: 18320692
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug interactions. Kaletra and ezetimibe.
    TreatmentUpdate; 2006; 18(3):8. PubMed ID: 17209242
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions. Kaletra and atazanavir.
    TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.